search
Back to results

Cognitive Behavioural Therapy for Social Phobia in People With Bipolar Disorder

Primary Purpose

Social Phobia, Bipolar Disorder

Status
Completed
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
Cognitive behavioural therapy (CBT)
Sponsored by
Nova Scotia Health Authority
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Social Phobia focused on measuring social phobia, bipolar disorder, cognitive behavioural therapy

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • A diagnosis of bipolar disorder I or II according to DSM-IV criteria and established in a structured interview
  • Bipolar disorder in remission for at least 12 weeks; defined as absence of depressive or manic episode according to DSM-IV criteria established in a structured interview and confirmed by Montgomery-Åsberg Depression Rating Scale score ≤ 12 and Young Mania Rating Scale score ≤ 7
  • Stable medication regime for at least 4 weeks prior to commencing CBT
  • Current diagnosis of social phobia according to DSM-IV criteria and established in a structured interview, including duration of social phobia of at least 6 months irrespective of age.
  • Social phobia is one of the primary complains (when bipolar disorder is in remission), justifying a therapeutic focus on this disorder.
  • Ability and willingness to consent to treatment
  • Ability to speak and write English

Exclusion Criteria:

  • Current substance use disorder
  • A previous adequate course of CBT for social phobia (at least 8 sessions) delivered by a trained therapist
  • Currently receiving any psychological therapy
  • Cognitive impairment that would preclude psychological therapy
  • Actively suicidal

Sites / Locations

  • Queen Elizabeth II Health Sciences Centre

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Cognitive behavioural therapy

Arm Description

Cognitive behavioural therapy for social phobia in people with bipolar disorder

Outcomes

Primary Outcome Measures

Acceptability of cognitive behavioural therapy for comorbid social phobia in bipolar disorder
Acceptability of cognitive behavioural therapy for comorbid social phobia in bipolar disorder will be assessed as proportion of offered sessions attended
Change on the Social Phobia Inventory (SPIN)

Secondary Outcome Measures

Change on the Liebowitz Social Anxiety Scale Scale Self-Report; Social Phobia Scale & Social Interaction Anxiety Scale; Social Phobia and Anxiety Inventory
Presence/absence of the social phobia diagnosis
Presence/absence of the social phobia diagnosis as established by Structured Clinical Interview for DSM Disorders
Depression symptom change
Depression symptom change as established by the Montgomery-Åsberg Depression Rating Scale and Beck Depression Inventory II
Mania symptom change
Change in symptoms of mania as established by the Young Mania Rating Scale

Full Information

First Posted
November 27, 2012
Last Updated
November 9, 2022
Sponsor
Nova Scotia Health Authority
search

1. Study Identification

Unique Protocol Identification Number
NCT01736631
Brief Title
Cognitive Behavioural Therapy for Social Phobia in People With Bipolar Disorder
Official Title
Cognitive Behavioural Therapy for Social Phobia in People With Bipolar Disorder: A Pilot Study
Study Type
Interventional

2. Study Status

Record Verification Date
June 2017
Overall Recruitment Status
Completed
Study Start Date
March 2013 (Actual)
Primary Completion Date
January 24, 2019 (Actual)
Study Completion Date
September 9, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Nova Scotia Health Authority

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
We are doing this study to find out how well cognitive behavioural therapy for social phobia works in people with bipolar disorder, who also have social phobia.
Detailed Description
Social phobia is a very prevalent anxiety disorder in people with bipolar disorder and is associated with adverse outcomes. Yet, social phobia is treatable by cognitive behavioural therapy or antidepressant medication. As antidepressants are often contra-indicated in people with bipolar disorder, cognitive behavioural therapy is the likely first choice treatment for social phobia in this population. However, people with bipolar disorder were excluded from previous clinical trials on treatment of social phobia. Our aim is to evaluate the acceptability and to provide a rough estimate of efficacy of cognitive behavioural therapy protocol for social phobia in people with bipolar disorder in a systematic case series. We will also prepare pilot data for evaluating the impact of treatment of comorbid social phobia on the long-term course of bipolar disorder.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Social Phobia, Bipolar Disorder
Keywords
social phobia, bipolar disorder, cognitive behavioural therapy

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
9 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Cognitive behavioural therapy
Arm Type
Experimental
Arm Description
Cognitive behavioural therapy for social phobia in people with bipolar disorder
Intervention Type
Behavioral
Intervention Name(s)
Cognitive behavioural therapy (CBT)
Intervention Description
The CBT intervention will follow the model of social phobia by Clark & Wells (Clark & Wells, 1995; Clark, 2005). The main elements of CBT for social phobia include reducing self-focus, dropping safety behaviours, and testing negative cognitions.
Primary Outcome Measure Information:
Title
Acceptability of cognitive behavioural therapy for comorbid social phobia in bipolar disorder
Description
Acceptability of cognitive behavioural therapy for comorbid social phobia in bipolar disorder will be assessed as proportion of offered sessions attended
Time Frame
up to end of treatment (20 weeks)
Title
Change on the Social Phobia Inventory (SPIN)
Time Frame
Baseline and end of treatment (20 weeks)
Secondary Outcome Measure Information:
Title
Change on the Liebowitz Social Anxiety Scale Scale Self-Report; Social Phobia Scale & Social Interaction Anxiety Scale; Social Phobia and Anxiety Inventory
Time Frame
Baseline and end of treatment (20 weeks)
Title
Presence/absence of the social phobia diagnosis
Description
Presence/absence of the social phobia diagnosis as established by Structured Clinical Interview for DSM Disorders
Time Frame
Baseline and end of treatment (20 weeks)
Title
Depression symptom change
Description
Depression symptom change as established by the Montgomery-Åsberg Depression Rating Scale and Beck Depression Inventory II
Time Frame
Baseline and end of treatment (20 weeks)
Title
Mania symptom change
Description
Change in symptoms of mania as established by the Young Mania Rating Scale
Time Frame
Baseline and end of treatment (20 weeks)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: A diagnosis of bipolar disorder I or II according to DSM-IV criteria and established in a structured interview Bipolar disorder in remission for at least 12 weeks; defined as absence of depressive or manic episode according to DSM-IV criteria established in a structured interview and confirmed by Montgomery-Åsberg Depression Rating Scale score ≤ 12 and Young Mania Rating Scale score ≤ 7 Stable medication regime for at least 4 weeks prior to commencing CBT Current diagnosis of social phobia according to DSM-IV criteria and established in a structured interview, including duration of social phobia of at least 6 months irrespective of age. Social phobia is one of the primary complains (when bipolar disorder is in remission), justifying a therapeutic focus on this disorder. Ability and willingness to consent to treatment Ability to speak and write English Exclusion Criteria: Current substance use disorder A previous adequate course of CBT for social phobia (at least 8 sessions) delivered by a trained therapist Currently receiving any psychological therapy Cognitive impairment that would preclude psychological therapy Actively suicidal
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Barbara Pavlova, PhD DClinPsy
Organizational Affiliation
Capital Health, Canada
Official's Role
Principal Investigator
Facility Information:
Facility Name
Queen Elizabeth II Health Sciences Centre
City
Halifax
State/Province
Nova Scotia
ZIP/Postal Code
B3H 2E2
Country
Canada

12. IPD Sharing Statement

Learn more about this trial

Cognitive Behavioural Therapy for Social Phobia in People With Bipolar Disorder

We'll reach out to this number within 24 hrs